PPARG and metabolic dysfunction-associated steatotic liver disease: While most evidence shows that PPARγ expression increases in diabetic or obesity models of NAFLD [48] and suggest a deleterious and lipogenic role for hepatic PPARγ in NAFLD [49], others suggest a beneficial role for PPARγ [50,51].